Heart Failure With Reduced Ejection Fraction: A Review

Review from the US perspective summarises the epidemiology, pathophysiology, diagnosis, management, and prognosis of heart failure with reduced ejection fraction. Despite recent developments, morbidity and mortality remain high, with a 5-year survival of 25% after hospitalisation


Journal of the American Medical Association